|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1995-2-22
|
|
pubmed:abstractText |
Despite effective treatments, the morbidity and mortality of obstructive airways disease (asthma and COPD) remains high. Home monitoring of peak expiratory flow (PEF) is increasingly being advocated as an aid to better management of obstructive airways disease. The few available studies describing effects of treatment on the level and variation of PEF have involved relatively small numbers of subjects and did not use control groups.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-1355640,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-1357553,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-1533595,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-1546839,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-1546857,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-1736734,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-1825099,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-1847158,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-1877037,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-1952426,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-1977482,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-1990947,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-2024810,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-2024843,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-2500361,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-2669579,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-2675701,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-2817599,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-3365860,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-3406912,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-3538479,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-6890243,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-7466721,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831626-8339808
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0040-6376
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1109-15
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:7831626-Adolescent,
pubmed-meshheading:7831626-Adult,
pubmed-meshheading:7831626-Asthma,
pubmed-meshheading:7831626-Beclomethasone,
pubmed-meshheading:7831626-Circadian Rhythm,
pubmed-meshheading:7831626-Double-Blind Method,
pubmed-meshheading:7831626-Drug Therapy, Combination,
pubmed-meshheading:7831626-Female,
pubmed-meshheading:7831626-Follow-Up Studies,
pubmed-meshheading:7831626-Forced Expiratory Volume,
pubmed-meshheading:7831626-Humans,
pubmed-meshheading:7831626-Ipratropium,
pubmed-meshheading:7831626-Lung Diseases, Obstructive,
pubmed-meshheading:7831626-Male,
pubmed-meshheading:7831626-Middle Aged,
pubmed-meshheading:7831626-Peak Expiratory Flow Rate,
pubmed-meshheading:7831626-Terbutaline
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group.
|
|
pubmed:affiliation |
Department of Pulmonology, University Hospital Groningen.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
